Clinical trial
Liposomal Bupivacaine vs. Interscalene Nerve Block for Pain Control After Total Shoulder Arthroplasty: A Randomized Clinical Trial
NCT02762071 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Liposomal Bupivacaine vs. Interscalene Nerve Block for Pain Control After Total Shoulder Arthroplasty: A Randomized Clinical Trial
- Lead sponsor
- Johns Hopkins University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2016
- Completion date
- April 15, 2019
- Enrollment
- 108 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
arthropathy, closed fracture proximal humerus, four part, osteoarthritis, shoulder pain